• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Union Spring Pharmaceuticals

edit

Union Springs Pharmaceuticals (USP) is a specialty OTC company that licenses, develops and commercializes innovative OTC products for the consumer and healthcare markets. They specialize in finding unique solutions for unmet consumer and healthcare professional needs. They provide focused, disciplined management to optimize products and technologies, and we apply industry-recognized scientific methods, clinical trials and testing methodologies to provide safe, effective products to our customers.

Milestones

edit

• 
  Union Spring Pharmaceuticals received $5M in Series A funding. (10/09)
  Posted 10/20/09 at 9:29pm
• 
  Union Spring Pharmaceuticals invested in Xanodyne. (6/23/09)
  Posted 6/23/09 at 10:21am

Videos

Screenshots

edit

Sources

1. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
2. Union Springs Pharmaceuticals, Inc.: Series A $5M (onbiovc.com) [edit]